These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 28533357)

  • 1. TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs.
    Won H; Moreira D; Gao C; Duttagupta P; Zhao X; Manuel E; Diamond D; Yuan YC; Liu Z; Jones J; D'Apuzzo M; Pal S; Kortylewski M
    J Leukoc Biol; 2017 Aug; 102(2):423-436. PubMed ID: 28533357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients.
    Hossain DM; Pal SK; Moreira D; Duttagupta P; Zhang Q; Won H; Jones J; D'Apuzzo M; Forman S; Kortylewski M
    Clin Cancer Res; 2015 Aug; 21(16):3771-82. PubMed ID: 25967142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells.
    Moreira D; Zhang Q; Hossain DM; Nechaev S; Li H; Kowolik CM; D'Apuzzo M; Forman S; Jones J; Pal SK; Kortylewski M
    Oncotarget; 2015 Jul; 6(19):17302-13. PubMed ID: 26046794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities.
    Kortylewski M; Moreira D
    Cancer Immunol Immunother; 2017 Aug; 66(8):979-988. PubMed ID: 28214929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer.
    Chen H; Yang K; Pang L; Fei J; Zhu Y; Zhou J
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Myeloid-Derived Suppressor Cells in High-Dose-Irradiated TRAMP-C1 Tumors: A Therapeutic Target and an Index for Assessing Tumor Microenvironment.
    Fu SY; Chen FH; Wang CC; Yu CF; Chiang CS; Hong JH
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1547-1558. PubMed ID: 33188861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of Ly6G
    Heim CE; West SC; Ali H; Kielian T
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30249747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualization and quantification of
    Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
    Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal and spatial profile of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in ischemic stroke in mice.
    Kawano T; Shimamura M; Nakagami H; Kanki H; Sasaki T; Mochizuki H
    PLoS One; 2019; 14(5):e0215482. PubMed ID: 31048856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer.
    Song J; Lee J; Kim J; Jo S; Kim YJ; Baek JE; Kwon ES; Lee KP; Yang S; Kwon KS; Kim DU; Kang TH; Park YY; Chang S; Cho HJ; Kim SC; Koh SS; Kim S
    Oncotarget; 2016 Aug; 7(32):51840-51853. PubMed ID: 27322081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
    Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
    Front Immunol; 2020; 11():613215. PubMed ID: 33679700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDR2/STAT3 Positive Feedback Loop Mediates the Immunosuppressive Microenvironment by Upregulating PD-L1 and Recruiting MDSCs in Oxaliplatin-Resistant HCC.
    Liu W; Zhang F; Quan B; Yao F; Chen R; Ren Z; Dong L; Yin X
    Cell Mol Gastroenterol Hepatol; 2024; 18(4):101377. PubMed ID: 38969205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 Expression.
    Patel A; Oba T; Kajihara R; Yokoi T; Abrams SI; Ito F
    J Immunol; 2021 Sep; 207(5):1298-1309. PubMed ID: 34362833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers.
    Moreira D; Adamus T; Zhao X; Su YL; Zhang Z; White SV; Swiderski P; Lu X; DePinho RA; Pal SK; Kortylewski M
    Clin Cancer Res; 2018 Dec; 24(23):5948-5962. PubMed ID: 30337279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer.
    Jachetti E; Cancila V; Rigoni A; Bongiovanni L; Cappetti B; Belmonte B; Enriquez C; Casalini P; Ostano P; Frossi B; Sangaletti S; Chiodoni C; Chiorino G; Pucillo CE; Tripodo C; Colombo MP
    Cancer Immunol Res; 2018 May; 6(5):552-565. PubMed ID: 29523597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD205
    Fu C; Fu Z; Jiang C; Xia C; Zhang Y; Gu X; Zheng K; Zhou D; Tang S; Lyu S; Ma S
    Cancer Sci; 2021 Mar; 112(3):1011-1025. PubMed ID: 33368883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs.
    Tannenbaum CS; Rayman PA; Pavicic PG; Kim JS; Wei W; Polefko A; Wallace W; Rini BI; Morris-Stiff G; Allende DS; Hamilton T; Finke JH; Diaz-Montero CM
    Cancer Immunol Res; 2019 Oct; 7(10):1687-1699. PubMed ID: 31439615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMP-9-cleaved osteopontin isoform mediates tumor immune escape by inducing expansion of myeloid-derived suppressor cells.
    Shao L; Zhang B; Wang L; Wu L; Kan Q; Fan K
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1478-1484. PubMed ID: 28986261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of myeloid-derived suppressor cells in prostate cancer murine models and patients following white button mushroom treatment.
    Wang X; Ma S; Twardowski P; Lau C; Chan YS; Wong K; Xiao S; Wang J; Wu X; Frankel P; Wilson TG; Synold TW; Presant C; Dorff T; Yu J; Sadava D; Chen S
    Clin Transl Med; 2024 Oct; 14(10):e70048. PubMed ID: 39390760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.